ArticleCancer discovery2015
Predicting cancer drug response: advancing the DREAM.
Article in Cancer discovery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.Genome biology · 2019Article
- Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin.Pharmaceutics · 2019Article
- KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images.Journal of cheminformatics · 2019Article
- Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nature genetics · 2018Article
- Predicting ligand-dependent tumors from multi-dimensional signaling features.NPJ systems biology and applications · 2017Article
- Biomolecular Network-Based Synergistic Drug Combination Discovery.BioMed research international · 2016Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
The DREAM challenge is a community effort to assess current capabilities in systems biology. Two recent challenges focus on cancer cell drug sensitivity and drug synergism, and highlight strengths and weaknesses of current approaches.
Indexed as
Identifiers
25623160What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.